Non-restraint in pediatric ankle sprain: a non-inferiority randomized clinical trial Authors: Sara Suarez-Cabezas, Begoña Perez-Moneo, Maria Cabrerizo Ortiz, Monica Hortigüela Aparicio, Carmen Gómez Gérez, Elisa M. Molanes-López, Ricardo Larrainzar-Garijo, Paula Vazquez Lopez Published: 2024 ABSTRACT Ankle sprains are common injuries in pediatric populations, yet current literature lacks consensus on optimal management strategies. This study aimed to compare the effectiveness of non-restraint treatment versus bandaging in children with mild ankle sprains, focusing on functional recovery and pain management.A single-center, open-label, non-inferiority randomized clinical trial was conducted at a pediatric emergency service. Patients aged 5–16 years with mild ankle sprains were included. Participants were randomized in a 1:1 ratio to receive either a standardized functional bandage or only general measures with non-restraint. The primary endpoints were a 10-point difference in the OXAFQ-C and a 2-point difference in pain intensity at day 5 after discharge. A total of 113 participants were randomly assigned to receive a functional bandage (n = 51) or non-restraint measures (n = 62). At day 5, the OXAFQ-C score in the non-restraint group was 76.59 (SD 15.51) and 69.71 (SD 15.24) in the restraint group, with a mean difference of 6.295 (90% CI − 0.058 to 12.647). The mean difference in pain intensity was 0.048 (90% CI − 0.741 to 0.838). No differences were observed in the OXAFQ-C scores or pain intensity at 14 and 30 days. Conclusions: This single-center, randomized clinical trial demonstrates that non-restraint is non-inferior to bandaging for functional recovery and short- to medium-term pain management in pediatric patients with mild ankle sprains. The treatment was very well accepted among patients and no adverse effects were reported.Trial registration: Retrospectively registered in January 2024 on clinicaltrials.org with identifier: NCT06189625. What is Known• Current literature lacks consensus on optimal ankle sprain management, with no evidence supporting non-restraint approaches. Guidelines recommend immobilization despite insufficient comparative data on different restraint systems. Some studies seem to demonstrate that early mobilization may offer better outcomes.What is New• This study contributes novel evidence by demonstrating the non-inferiority of non-restraint treatment compared to bandaging in pediatric ankle sprains. It highlights the safety and efficacy of early mobilization without restraint, suggesting a potential shift in standard management practices. Introduction Ankle sprains are common injuries, with a global incidence rate of 2.15 per 1000 people per year [1–5]. Classification of ankle sprains relies on subjective criteria [6], with most systems using a three-grade scale (mild, moderate, and severe). A mild sprain is characterized by intact ligament fibers that sustain only microscopic damage, leading to slight swelling and tenderness but usually maintaining the ability to bear weight and joint stability [5–7]. The initial treatment for ankle sprains typically follows the R.I.C.E. or P.R.I.C.E. method (Protect, Rest, Ice, Compression, Elevation). While analgesics and ice are effective for pain relief, there is no consensus on the benefits of elevation, compression, or rest. Current recommendations favor early support and gradual mobilization as tolerated. Recently, the P.R.I.C.E. method has evolved into P.O.L.I.C.E. (Protection, Optimal Loading, Ice, Compression, Elevation), with some authors proposing the P.E.A.C.E. and L.O.V.E. approach, emphasizing minimal anti-inflammatory use to support tissue healing [8]. Nonetheless, these recommendations are based on adult studies, where the evidence remains controversial [5, 9–11]. There are no studies exclusively involving pediatric populations or subgroup analyses focused on this age group. No studies have compared restraint or supportive treatment to non-restraint intervention. At our center, approximately half of pediatric patients diagnosed with mild ankle sprains receive treatment using anti-inflammatory drugs and relative rest, without external ankle support. Re-presentation to the emergency department rates are low, approximately 0.03%, and complications exceptionally rare [12]. Based on these findings, the study aims to demonstrate the non-inferiority of non-restraint compared to restraint in treating pediatric patients with mild ankle sprains. Methodology Study design A single-center, open-label, randomized, parallel, non-inferiority clinical trial was conducted at a general hospital. The study received ethical committee approval from our institution and was registered on clinicaltrials.org with identifier: NCT06189625. Population The study included patients diagnosed with mild ankle sprain treated in the pediatric emergency service (PES) of our center. A mild or grade I sprain was defined as presenting with mild edema, involvement of a single ligament (detected by palpation), and no joint instability (assessed using the anterior drawer and talar tilt tests) [7]. Inclusion criteria were: age between 5 and 16 years, diagnosis of grade I sprain, and informed consent signed by parents. Exclusion criteria included: chronic foot and/or ankle injury, pre-existing conditions with an increased risk of fractures, developmental disorders, presence of a penetrating injury or other associated musculoskeletal injuries, such as fractures, apophyseal lesions, etc., injury occurring more than 72 h prior, inability for telephone contact, or language barrier. Randomization and blinding The randomization sequence was created using Epidat 4.2 software, ensuring allocation concealment, with a constant 1:1 allocation ratio. Upon evaluation by a pediatrician and diagnosis of mild ankle sprain, patients and their guardians were invited to participate in the study and provided with all necessary information as recommended by the Helsinki Declaration. Upon agreement to participate, informed consent was obtained. Then, the treatment group assignment was revealed to both the attending physician and the patient. Blinding of the treatment at the time of care and during clinical reviews or data analysis was not possible due to the nature of the intervention. Procedure During history taking and physical examination, age, sex, relevant personal history, and previous ankle sprains on the same side were documented. Injury mechanism, time until arrival at the PES, prior analgesia administration, and pain level using a numerical scale (0–10) were also recorded. Physical examination documented pain location, inability to take more than two steps at the consultation, and presence of edema, bruising, or joint instability. Adequate analgesia was ensured during the emergency consultation. Once the informed consent was signed, each patient was randomly assigned to either the restraint group, where a functional bandage was applied for 5 days, or the non-restraint group, where only common recommendations were implemented. Due to financial constraints and the need to use a standardized type of restraint during emergency care to minimize heterogeneous results in the restraint group, the following functional bandage was chosen (Fig. 1). It consisted of a standardized bandage using 6 cm silk tape and 7.5 cm Tensoplast. Emergency nurses underwent dual training, consisting of an instructional video and a half-hour practical session. Reminder posters were placed in the procedure room where such interventions are typically performed.Fig. 1Functional bandage technique Functional bandage technique All patients, from both restraint and non-restraint groups, were provided with common recommendations upon discharge. They were advised to take ibuprofen for 2–3 days and subsequently if in pain, as well as to apply local cold for a maximum of 10 min several times a day. Relative rest was recommended, encouraging weight-bearing as tolerated, and using crutches if necessary. All patients were advised to refrain from sports for at least a week or more if needed and resume athletic activity, gradually, once pain-free during ambulation. The use of an elastic ankle brace only during sports activity was also recommended for the following weeks or months after the injury to prevent re-injury. Four researchers conducted follow-up calls to patients at 5 , 14, and 30 days post-injury using a predefined questionnaire. If no response was received on the first attempt, a second call was made the same day, and in case of a repeated lack of response, another attempt was made the following day, with a non-response recorded as a loss. For patients who did not respond to two or more follow-ups, a review of the electronic medical record was conducted in the month following their initial emergency visit via a centralized database, which records any visit to a public healthcare facility, whether primary care or hospital, in the province where the study was conducted. Study data were collected and managed using REDCap electronic data capture tools hosted at our institution. Outcomes The primary outcome assessed was the score on “The Oxford Ankle Foot Questionnaire for Children” (OXAFQ-C) (https://acortar.link/oFt4Ne) at 5, 14, and 30 days, a validated scale for the pediatric population aged 5 to 16 years to assess the functionality of the injured ankle, comprising 14 items across three domains: physical, social/daily activities, and emotional. Each item is scored on a frequency scale: never (4), rarely (3), sometimes (2), often (1), always (0). Higher scores indicate better functionality. This scale can also be converted into a percentage scale. A difference of more than 10 points in the OXAFQ-C percentage score was considered clinically significant. Licenses for academic use were obtained prior to study commencement. As secondary variables, both groups were assessed for the presence of pain at the time of review (PES and 5, 14, and 30 days follow-up) and, if pain was present, its severity on a numerical scale (0–10). Days requiring oral analgesia and days requiring crutches use were also recorded. It was also documented, for the restraint group, adverse effects of the bandage and tolerance to it using an ordinal scale (very poor, poor, fair, good, very good). In the non-restraint group, the use of an elastic ankle brace or any other form of restraint despite recommendations was recorded. Finally, patient satisfaction regarding the care received in the PES, the assigned treatment, and their recovery was recorded using a numerical scale (0–10). Statistical analysis In the absence of previous studies evaluating the use of non-restraint approaches in patients with ankle sprains, as well as research investigating the outcomes of the OXAFQ-C questionnaire during their recovery process, the initial sample size calculation assumed a non-inferiority margin of 10 points on the percentage scale of the OXAFQ-C at 5 days and a standard deviation (SD) of 25 for this calculation. Thus, comparing two independent means with a two-sided test and balanced random allocation (Group 1 size/Group 2 size ratio = 1), with an alpha risk of 5% and a power of 80%, the calculated sample size was 156 patients (78 in each group). Assuming a dropout rate of 10%, the established sample size was 172 (86 in each group). Due to the lack of prior data, an interim analysis was planned after the inclusion of the first 50 patients to recalculate the sample size. With the preliminary data obtained, the final estimated sample size was 100 (50 in each group) for a non-inferiority margin of 10 points on the OXAFQ-C percentage scale at 5 days, an SD of 15, an alpha risk of 5%, a power of 90%, and a dropout rate of 30%. An intention-to-treat analysis and a per-protocol analysis were planned. Given an estimated loss to follow-up greater than 5% but less than 40%, the best–worst case analysis proposed by Jakobsen et al. [13] was used, where missing data from the restraint group were replaced with the mean + 1 SD of that group (beneficial outcome) and those from the non-restraint group with the mean − 1 SD (harmful outcome). Categorical variables were described using percentages, and continuous variables as means and standard deviations (SD) if normally distributed (Kolmogorov–Smirnov and/or Shapiro–Wilk) or medians and interquartile ranges otherwise. The bivariate analysis of categorical variables was conducted using the Chi-square test or Fisher's exact test, and that of continuous variables with the Student’s t-test or its non-parametric equivalent (the Mann–Whitney U test). All statistical tests were considered significant at a 5% level. The analysis was performed using JASP software version 0.18. Results Between September 2021 and April 2022, 192 patients were diagnosed with mild ankle sprain, of which 113 were included in the study. The flow diagram is presented in Fig. 2.Fig. 2Consolidated Standards of Reporting Trials diagram. aA per-protocol analysis was conducted at the 5-day review, excluding patients who used an elastic ankle brace contrary to recommendations Consolidated Standards of Reporting Trials diagram. aA per-protocol analysis was conducted at the 5-day review, excluding patients who used an elastic ankle brace contrary to recommendations The mean age was 11.12 years (SD 2.86), with 52.68% being male (no difference compared to the reference population). The time from injury to care in the PES was 15.64 h (SD 16.24), with 29% (32/110) having received analgesia prior to arrival at the emergency department. Following assignment to treatment groups, baseline characteristics were comparable between groups (Table 1) except for the variable “inability to walk in the PES,” which, due to its potential as a confounding factor, will be analyzed separately in another section. Table 1Baseline characteristicsCharacteristicsParticipantsNon-restraint group n = 62Restraint Group n = 51TotalAge10.98 (2.74)11.29 (3.02)11.12 (2.86)GenderFemale30 (48.39)23 (46)53 (47.32)Male32 (51.61)27 (54)59 (52.68)BMI20.08 (4.97)20.30 (13.3)20.17 (4.99)Previous sprains15 (24.59)10 (20.41)25 (25)LateralityRight35 (56.45)26 (50.98)61 (53.98)Left27 (43.55)25 (49.02)52 (46.02)MechanismInversion34 (54.84)32 (62.75)66 (58.419Eversion11 (17.74)8 (15.69)19 (16.81)Hyperflexion01 (1.96)1 (0.88)Direct Trauma1 (1.61)2 (3.92)3 (2.65)Unknown16 (25.81)8 (15.69)24 (21.4)LocationInternal9 (14.52)6 (11.76)15 (13.27)External44 (70.97)38 (74.51)82 (72.57)Midfoot4 (6.45)5 (9.8)9 (7.96)Generalized5 (8.06)2 (3.92)7 (6.19)Time from injury to visit13,96 (14.27)17,65 (18.27)15,64 (16.24)Prior analgesia18 (30.51)14 (27.45)32 (29.09)Pain severity5.11 (2.14)5.09 (2.19)5.1 (2.15)Presence of edema10 (16.95)16 (31.37)26 (23.64)Presence of hematoma5 (8.06)4 (8)9 (8.04)Inability to walk3 (4.84)*16 (31.37)*19 (16.81)Data are n (%) or mean (SD). Percentages may not total 100 because of rounding*p value = 0.0002 Table 1Baseline characteristicsCharacteristicsParticipantsNon-restraint group n = 62Restraint Group n = 51TotalAge10.98 (2.74)11.29 (3.02)11.12 (2.86)GenderFemale30 (48.39)23 (46)53 (47.32)Male32 (51.61)27 (54)59 (52.68)BMI20.08 (4.97)20.30 (13.3)20.17 (4.99)Previous sprains15 (24.59)10 (20.41)25 (25)LateralityRight35 (56.45)26 (50.98)61 (53.98)Left27 (43.55)25 (49.02)52 (46.02)MechanismInversion34 (54.84)32 (62.75)66 (58.419Eversion11 (17.74)8 (15.69)19 (16.81)Hyperflexion01 (1.96)1 (0.88)Direct Trauma1 (1.61)2 (3.92)3 (2.65)Unknown16 (25.81)8 (15.69)24 (21.4)LocationInternal9 (14.52)6 (11.76)15 (13.27)External44 (70.97)38 (74.51)82 (72.57)Midfoot4 (6.45)5 (9.8)9 (7.96)Generalized5 (8.06)2 (3.92)7 (6.19)Time from injury to visit13,96 (14.27)17,65 (18.27)15,64 (16.24)Prior analgesia18 (30.51)14 (27.45)32 (29.09)Pain severity5.11 (2.14)5.09 (2.19)5.1 (2.15)Presence of edema10 (16.95)16 (31.37)26 (23.64)Presence of hematoma5 (8.06)4 (8)9 (8.04)Inability to walk3 (4.84)*16 (31.37)*19 (16.81)Data are n (%) or mean (SD). Percentages may not total 100 because of rounding*p value = 0.0002 Baseline characteristics Data are n (%) or mean (SD). Percentages may not total 100 because of rounding *p value = 0.0002 At 5 days, the OXAFQ-C score in the non-restraint group was 76.59 (SD 15.51) and in the restraint group 69.71 (SD 15.24), with a mean difference of 6.87 (95% CI 0.02–13.72). No differences were observed in the OXAFQ-C scores at 14 and 30 days (Fig. 3).Fig. 3OXAFQ-C results OXAFQ-C results Up to 40% (18/45) of patients in the non-restraint group used an elastic ankle brace despite established recommendations. When conducting a per-protocol analysis, the difference between groups is larger with a score on the OXAFQ-C scale at 5 days in the non-restraint group of 80.56 (SD 15.51) and in the restraint group of 69.24 (SD 15.18), with a mean difference of 11.33 (95% CI 4.07–18.56) (Fig. 3). Analysis of principal variables The non-inferiority of non-restraint compared to restraint was demonstrated in terms of OXAFQ-C scores at 5, 14, and 30 days, considering a clinically relevant difference of 10 points. The analysis also established the non-inferiority of non-restraint compared to restraint in terms of pain severity, considering a clinically relevant difference of 2 points in the numeric scale. Figure 4 shows that both the mean differences and their 90% CI are completely within the non-inferiority region, that is, to the right of the non-inferiority limit (− 10 for OXAFQ-C and − 2 for pain severity).Fig. 4Non-inferiority analysis of OXAFQ-C results and pain intensity Non-inferiority analysis of OXAFQ-C results and pain intensity Analysis of possible confounding factor: inability to walk in the PES During planned interim analyses, an asymmetric distribution regarding the “inability to walk in the emergency” variable was noted. This was not attributed to a flaw in the randomization system. Given that initial inability to walk may be a determining factor in patients’ subsequent recovery, it was included in the ANOVA model as a potential confounding factor, although its interaction could not be included in the model due to lack of data. There was only one patient with an inability to walk in the non-restraint group (Fig. 5). No differences were found between treatment groups in the OXAFQ-C score at 5 days. The results of various analyses are shown in Fig. 6.Fig. 5Distribution of weight-bearing and non-weight-bearing patients between the two treatment groupsFig. 6Analysis of the confounding factor “non-weight-bearing” Distribution of weight-bearing and non-weight-bearing patients between the two treatment groups Analysis of the confounding factor “non-weight-bearing” Since including patients with an inability to walk might introduce selection bias, as these could be patients with moderate rather than mild sprain, a modified intention-to-treat analysis excluding patients with this potential confounding factor was conducted, yielding better outcomes in the non-restraint group compared to the restraint group (Fig. 6). Analysis of secondary variables Fewer patients used crutches in the non-restraint group than in the restraint group, with a RAR of 26.16% (95% CI 6.84–45.48%) and a NNT of 4 (95% CI 3–15). Although this might be related to a higher distribution of patients with an inability to walk in the restraint group, this could not be demonstrated: 53.33% of patients unable to walk used crutches compared to 33.33% of those who could walk, with a RRR of − 39.13% (95% CI − 124.35 to 46.09%) and RAR of −10.49% (95% CI −31.19 to 10.21%), p value 0.3419. No differences were found in pain control, number of recurrences, and patient satisfaction regarding treatment (Table 2). Table 2Other outcomesOutcomeNon-restraint groupRestraint groupRRR % (95% CI)ARR % (95% CI)NNT (95% CI)pDays with ibuprofen4.09 (1.29)3.88 (1.74)N/AN/AN/A0.6903Pain at 5 days-review41.30 (19/46)37.5 (15/40) − 0.10 (− 0.87 to 0.35) − 0.04 (− 0.24 to 0.17)N/A0.7189Pain at 14 days-review25.64 (10/39)32.43 (12/37)0.21 (− 0.61 to 0.61)0.07 (− 0.14 to 0.27)N/A0.4707Pain at 30 days-review7.69 (3/39)13.89 (5/36)0.45 (− 1.15 to 0.86)0.06 (− 0.08 to 0.20)N/A0.3108Pain severity at 5 days-review4.29 (1.44)4.53 (1.61)N/AN/AN/A0.9257Pain severity at 14 days-review4.20 (1.55)3.64 (1.80)N/AN/AN/A0.4302Pain severity at 30 days-review3.33 (0.58)3.00 (1.15)N/AN/AN/A0.8516Use of crutches23.91 (11/46)51.22 (21/41)0.53 (0.15 to 0.74)0.27 (0.08 to 0.47)3.66 (2.13–13.06)0.0084Days with crutches3.0 (1.26)3.95 (1.53)N/AN/AN/A0.0952Recurrence at 5 days-review2.17 (1/46)2.63 (1/38)0.17 (−11.77 to 0.95)0.004 (−0.06 to 0.07)N/A0.7030Recurrence at 14 days-review2.50 (1/40)0N/A − 0.03 (− 0.07 to 0.02)N/A0.7782Recurrence at 30 days-review2.56 (1/39)2.77 (1/36)0.08 (− 13.22 to 0.94)0.002 (− 0.07 to 0.08)N/A0.7329Satisfaction (emergency care)9.05 (1.45)9.23 (1.08)N/AN/AN/A0.7847Satisfaction (treatment)9.02 (1.52)9.17 (1.34)N/AN/AN/A0.6356Satisfaction (progression)9.06 (1.15)9.16 (1.30)N/AN/AN/A0.5560N/A, not applicable.Data are n (%) or mean (SD). Percentages may not total 100 because of rounding. Table 2Other outcomesOutcomeNon-restraint groupRestraint groupRRR % (95% CI)ARR % (95% CI)NNT (95% CI)pDays with ibuprofen4.09 (1.29)3.88 (1.74)N/AN/AN/A0.6903Pain at 5 days-review41.30 (19/46)37.5 (15/40) − 0.10 (− 0.87 to 0.35) − 0.04 (− 0.24 to 0.17)N/A0.7189Pain at 14 days-review25.64 (10/39)32.43 (12/37)0.21 (− 0.61 to 0.61)0.07 (− 0.14 to 0.27)N/A0.4707Pain at 30 days-review7.69 (3/39)13.89 (5/36)0.45 (− 1.15 to 0.86)0.06 (− 0.08 to 0.20)N/A0.3108Pain severity at 5 days-review4.29 (1.44)4.53 (1.61)N/AN/AN/A0.9257Pain severity at 14 days-review4.20 (1.55)3.64 (1.80)N/AN/AN/A0.4302Pain severity at 30 days-review3.33 (0.58)3.00 (1.15)N/AN/AN/A0.8516Use of crutches23.91 (11/46)51.22 (21/41)0.53 (0.15 to 0.74)0.27 (0.08 to 0.47)3.66 (2.13–13.06)0.0084Days with crutches3.0 (1.26)3.95 (1.53)N/AN/AN/A0.0952Recurrence at 5 days-review2.17 (1/46)2.63 (1/38)0.17 (−11.77 to 0.95)0.004 (−0.06 to 0.07)N/A0.7030Recurrence at 14 days-review2.50 (1/40)0N/A − 0.03 (− 0.07 to 0.02)N/A0.7782Recurrence at 30 days-review2.56 (1/39)2.77 (1/36)0.08 (− 13.22 to 0.94)0.002 (− 0.07 to 0.08)N/A0.7329Satisfaction (emergency care)9.05 (1.45)9.23 (1.08)N/AN/AN/A0.7847Satisfaction (treatment)9.02 (1.52)9.17 (1.34)N/AN/AN/A0.6356Satisfaction (progression)9.06 (1.15)9.16 (1.30)N/AN/AN/A0.5560N/A, not applicable.Data are n (%) or mean (SD). Percentages may not total 100 because of rounding. Other outcomes N/A, not applicable. Data are n (%) or mean (SD). Percentages may not total 100 because of rounding. In the restraint group, the bandage was poorly or very poorly tolerated by 7.5% of the patients (3/40), with 49.01% (25/51) experiencing side effects. Among these, 19.61% encountered skin issues, primarily pruritus (9/51) and in one case, erosions. 5.88% experienced pain associated with the bandage, and 3.92% reported pain upon removal. Venous stasis was reported in only one case. The remaining issues included the bandage becoming loose (7.84%) or getting wet (5.88%). In the non-restraint group, only one case of pruritus related to the use of an ankle brace was reported, with no adverse effects found in the rest of the patients. Analysis of loss during follow-up A review of the electronic medical records was conducted for those patients who had not responded to at least two follow-up calls. It was found that only 2 patients, one from each treatment group, had returned to a healthcare facility after their inclusion in the study, both due to the persistence of symptoms. Following the protocol, a best–worst-case analysis of the OXAFQ-C scores at 5 days was performed. When imputed according to the best–worst scenario, the average score in the restraint group increased from 69.72 to 74.21, while in the non-restraint group, it decreased from 76.59 to 72.34, with no significant difference between the two groups (p = 0.5047). No differences were observed when controlling for the confounding factor of 'inability to walk' (mean difference of − 2.74 (90% CI − 7.69 to 2.21, p value = 0.3603). Note that both the mean difference and its 90% CI fall within the non-inferiority region, that is, to the right of the established non-inferiority limit of − 10. Discussion This single-center, open-label, randomized clinical trial provides the first clinical evidence that non-restraint is non-inferior to bandaging regarding pain control and functional recovery in children diagnosed with mild ankle sprain. Ankle sprains present a clinical and public health challenge due to their high incidence and the impact of this condition on individuals' ability to maintain a physically active lifestyle [3]. However, there is a lack of consensus regarding the optimal approach to management. A 2019 study highlighted that clinical practice guidelines and protocols related to ankle sprain management are of low quality, inconsistent, and generally out of date [14]. While the P.R.I.C.E. method is commonly recommended, only the effectiveness of cryotherapy and oral analgesia in pain management has been validated [9, 15, 16]. Despite this lack of evidence, the standard practice is to recommend some form of restraint after initial care [5, 10]. Few studies have compared different restraint systems, and those conducted have not found substantial differences between them [5, 10, 17]. Consequently, some authors [18] recommend using removable and as simple as possible immobilizations to avoid potential complications associated with fixed immobilizations. Furthermore, some studies suggest that early mobilization within the first week, or even structured rehabilitation programs, can lead to improved functionality and better pain management outcomes [5, 18–20], prompting the development of strategies such as P.O.L.I.C.E. or P.E.A.C.E. and L.O.V.E. However, evidence regarding the actual impact of these methods on recovery remains insufficient. There is no consensus among authors on key aspects such as the type of protection recommended, the optimal loading regimen, or the timing and nature of a structured rehabilitation program. Our study confirms that early mobilization is a safe measure and demonstrates that restraint is not a necessary intervention for the proper recovery of patients with mild ankle sprain. This is the first study to evaluate non-restraint as a therapeutic option and the second [20] to explore different therapeutic options in the pediatric population. The study has some limitations. The diagnosis of mild sprain is subjective, based purely on clinical assessment. The review by Lacerda et al. [6] already points out that the lack of consensus regarding a severity classification system makes it difficult to predict patient prognosis and thus precisely compare different treatments in research studies. In this context, including patients unable to walk in this study could be questionable as it might correspond to a more severe initial condition. The uneven distribution of patients unable to walk in both patient groups makes it challenging to assess the role this factor may play in their functional recovery. To minimize this potential bias, it was included as a confounding factor in the statistical model, and various sub-analyses were conducted to determine its influence on the outcomes. Similar to other studies, blinding was impossible due to the intervention’s nature. Finally, we experienced high dropout rates during follow-up because some patient family members did not respond to telephone calls. However, these losses were similar between groups, suggesting that dropouts were not related to the intervention. This has been accounted for in the statistical analysis. Given these findings, we suggest that bandage is not necessary in children with mild ankle sprain, as non-restraint achieves similar functional outcomes, equal patient and family satisfaction, and presents no adverse effects compared to bandaging. This could represent a significant shift in the standard management of these patients. Conclusions This single-center, randomized clinical trial demonstrates that non-restraint is non-inferior to bandaging for functional recovery and short- to medium-term pain management in patients diagnosed with mild ankle sprain, with very good acceptance among treated patients and no adverse effects.